100% agreed Musky, the first two options would take the risk well out of this company.
First two options
- Licensing of ADAPT® technology to existing in-market TAVR and SAVR products
- Supply of ADAPT® treated material for current in-market products
Is the below study the final hurdle to getting these deals signed? Did he say study to be completed over the next couple of months?
Anti-Calcification Comparison Study
Confirm ADAPT® Technology’s superior resistance to calcification vs. a commercially available anti-calcification technology tissue commonly used in surgical and TAVR valves
Obviously, will also help with obtaining FDA fast track designation too.
Great presentation on a totally new company IMO
- Forums
- ASX - By Stock
- AVR
- My thoughts on the AHZ AGM presentation
My thoughts on the AHZ AGM presentation, page-9
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$12.95 |
Change
-0.350(2.63%) |
Mkt cap ! $265.2M |
Open | High | Low | Value | Volume |
$13.06 | $13.30 | $12.55 | $345.4K | 26.55K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4 | $12.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.88 | 569 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4 | 12.660 |
2 | 285 | 12.610 |
2 | 508 | 12.600 |
1 | 8 | 12.560 |
2 | 730 | 12.550 |
Price($) | Vol. | No. |
---|---|---|
12.880 | 569 | 2 |
12.890 | 110 | 1 |
12.920 | 2 | 1 |
13.000 | 1793 | 3 |
13.100 | 212 | 1 |
Last trade - 14.10pm 03/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |